174
Views
8
CrossRef citations to date
0
Altmetric
Articles

Model systems for rapid and slow induction of apoptosis obtained by inducible expression of pro-apoptotic proteins

, , , &
Pages 329-335 | Received 14 Nov 2012, Accepted 19 Nov 2012, Published online: 25 Jan 2013

References

  • Andersson Y., Juell S., Fodstad O.. Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor—Pseudomonas exotoxin A immunotoxin. Int. J. Cancer. 2004; 112:475–483.
  • Giansanti V., Tillhon M., Mazzini G., . Killing of tumor cells: a drama in two acts. Biochem. Pharmacol.. 2011; 82:1304–1310.
  • Hanahan D., Weinberg R. A.. The hallmarks of cancer. Cell. 2000; 100:57–70.
  • Strasser A., Cory S., Adams J. M.. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J.. 2011; 30:3667–3683.
  • Bondanza A., Zimmermann V. S., Rovere-Querini P., . Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J. Exp. Med.. 2004; 200:1157–1165.
  • Swann J. B., Smyth M. J.. Immune surveillance of tumors. J. Clin. Invest.. 2007; 117:1137–1146.
  • Ronchetti A., Rovere P., Iezzi G., . Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J. Immunol.. 1999; 163:130–136.
  • Huang Q., Li F., Liu X., . Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med.. 2011; 17:860–866.
  • Schulze C., Sarter K., Herrmann M.. Do we already understand all aspects connecting clearance and autoimmunity?. Autoimmunity. 2007; 40:239–243.
  • Bijl M., Reefman E., Limburg P. C., Kallenberg C. G.. Inflammatory clearance of apoptotic cells after UVB challenge. Autoimmunity. 2007; 40:244–248.
  • Lohmann C., Muschaweckh A., Kirschnek S., . Induction of tumor cell apoptosis or necrosis by conditional expression of cell death proteins: analysis of cell death pathways and in vitro immune stimulatory potential. J. Immunol.. 2009; 182:4538–4546.
  • Danke C., Grünz X., Wittmann J., . Adjusting transgene expression levels in lymphocytes with a set of inducible promoters. J. Gene Med.. 2010; 12:501–515.
  • Herr R., Wöhrle F. U., Danke C., Berens C., Brummer T.. A novel MCF-10A line allowing conditional oncogene expression in 3D culture. Cell Comm. Signal.. 2011; 9:17.
  • Knott A., Drueppel L., Beyer T., . An optimized conditional suicide switch using doxycycline-dependent expression of human tBid. Cancer Biol. Ther.. 2005; 4:532–536.
  • Srinivasula S. M., Ahmad M., MacFarlane M., . Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J. Biol. Chem.. 1998; 273:10107–10111.
  • Higuchi R., Krummel B., Saiki R. K.. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions. Nucl. Acids Res.. 1988; 16:7351–7367.
  • Baron U., Freundlieb S., Gossen M., Bujard H.. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucl. Acids Res.. 1995; 23:3605–3606.
  • Pop C., Salvesen G. S.. Human caspases: activation, specificity, and regulation. J. Biol. Chem.. 2009; 284:21777–21781.
  • Spencer S. L., Gaudet S., Albeck J. G., Burke J. M., Sorger P. K.. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature. 2009; 459:428–432.
  • Scaffidi C., Fulda S., Srinivasan A., . Two CD95 (APO-1/Fas) signaling pathways. EMBO J.. 1998; 17:1675–1687.
  • Shelton S. N., Shawgo M. E., Robertson J. D.. Cleavage of Bid by executioner caspases mediates feed forward amplification of mitochondrial outer membrane permeabilization during genotoxic stress-induced apoptosis in Jurkat cells. J. Biol. Chem.. 2009; 284:11247–11255.
  • Heyder P., Gaipl U. S., Beyer T. D., . Early detection of apoptosis by staining of acid-treated apoptotic cells with FITC-labeled lectin from Narcissus pseudonarcissus. Cytometry A. 2003; 55:86–93.
  • Erbacher A. I., Ronnefarth V. M., Decker P.. Circulating nucleosomes due to a defective clearance of dying cells: consequences for systemic lupus erythematosus. Autoimmunity. 2007; 40:311–314.
  • Meesmann H. M., Parcina M., Lorenz H. M., Blank N., Schiller M.. Apo material as a trigger for inflammation in systemic lupus erythematosus. Autoimmunity. 2009; 42:251–253.
  • Muñoz L. E., Janko C., Chaurio R. A., . IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE. Autoimmunity. 2010; 43:232–235.
  • Sato H., Frank D. W.. ExoU is a potent intracellular phospholipase. Mol. Microbiol.. 2004; 53:1279–1290.
  • Pattingre S., Tassa A., Qu X., . Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005; 122:927–939.
  • Lightfield K. L., Persson J., Brubaker S. W., . Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat. Immunol.. 2008; 9:1171–1178.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.